+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Implantable Cardioverter Defibrillators Market - Global Forecast 2026-2032- Product Image
Implantable Cardioverter Defibrillators Market - Global Forecast 2026-2032- Product Image
Sale

Implantable Cardioverter Defibrillators Market - Global Forecast 2026-2032

  • Report

  • 188 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5674806
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Implantable Cardioverter Defibrillators Market is projected to reach USD 5.28 Billion in 2026. It is expected to continue growing at a CAGR of 6.28%, reaching USD 7.66 Billion by 2032.

Implantable cardioverter defibrillators (ICDs) remain a cornerstone therapy for preventing sudden cardiac death in patients at high risk of life-threatening ventricular tachyarrhythmias. The clinical rationale is well established: cardiovascular disease is the world’s leading cause of death, with the World Health Organization reporting 17.9 million cardiovascular deaths in 2019, and major cardiology guidelines continue to support ICD therapy for eligible patients with reduced ejection fraction, prior cardiac arrest, or documented ventricular arrhythmias.

The implantable cardioverter defibrillators market is being shaped by an aging population, higher survival after myocardial infarction and heart failure, expanding electrophysiology capabilities, and stronger use of remote cardiac monitoring. Demand is concentrated across transvenous ICDs, subcutaneous ICDs, cardiac resynchronization therapy defibrillators, leads, pulse generators, and device management platforms, making the sector strategically important for medtech manufacturers, hospitals, payers, and digital health partners.

Transformative Shifts in the ICD Landscape

The ICD landscape is moving from device-centric intervention toward connected, outcomes-driven cardiac care. Remote monitoring, longer battery life, MRI-conditional labeling, improved lead design, and programming strategies that reduce inappropriate shocks are changing how clinicians manage patients after implantation. These advances support better continuity of care while reducing avoidable clinic burden.

Another major shift is the rising preference for personalized device selection. Transvenous ICDs remain widely used where pacing and defibrillation are both required, while subcutaneous ICDs are increasingly relevant for patients who need defibrillation without chronic intravascular leads. Health systems are also emphasizing shared decision-making, guideline adherence, infection prevention, and lifecycle cost management as ICD adoption expands.

Cumulative Impact of Artificial Intelligence on ICDs

Artificial intelligence is beginning to influence the ICD ecosystem through risk stratification, arrhythmia detection, remote monitoring triage, and predictive maintenance. AI-supported analytics can help clinicians prioritize alerts, identify changes in heart failure status, and interpret large volumes of rhythm and device data generated by connected cardiac implantable electronic devices.

The cumulative impact of AI is expected to be operational as much as clinical. Hospitals and device clinics face growing workloads from remote monitoring transmissions, and algorithmic triage can help focus clinician attention on actionable events. However, AI adoption must remain aligned with regulatory expectations, cybersecurity safeguards, transparent validation, and clinician oversight because ICD therapy decisions carry high patient-safety implications.

Key Regional Insights Across the ICD Market

North America continues to lead ICD adoption because of established electrophysiology networks, broad guideline awareness, advanced reimbursement pathways, and high prevalence of heart failure and ischemic heart disease. The United States anchors regional demand through large procedure volumes, regulated device innovation, and strong remote monitoring penetration, while Canada benefits from organized cardiac care pathways and public reimbursement structures.

Europe shows mature ICD utilization supported by European Society of Cardiology guidelines, national device registries, and strong hospital infrastructure in countries such as Germany, France, Italy, Spain, and the United Kingdom. Asia-Pacific is the fastest-evolving opportunity as China, India, Japan, South Korea, Australia, and ASEAN health systems expand access to electrophysiology services, although reimbursement variability, specialist distribution, and affordability remain key constraints.

Latin America, the Middle East, and Africa present uneven but meaningful development potential. Brazil and Mexico lead Latin American adoption through tertiary cardiac centers and expanding private-sector capability, while the Middle East is supported by specialty hospital investment, particularly across Gulf health systems. In Africa, demand is concentrated in major urban hospitals where device affordability, electrophysiology specialist availability, supply continuity, and post-implant follow-up infrastructure determine access.

Key Group Insights for ICD Commercial Strategy

The G7 represents the most commercially mature ICD environment, with advanced regulatory systems, established reimbursement, higher availability of electrophysiology specialists, and broad adoption of guideline-directed cardiovascular care. NATO members overlap heavily with developed North American and European markets, where procurement standards, cybersecurity expectations, supply-chain resilience, and secure remote monitoring infrastructure are increasingly relevant for connected ICD platforms.

The European Union is important for harmonized medical device oversight under the EU Medical Device Regulation and for cross-country evidence generation through registries, post-market surveillance, and health technology assessment. BRICS economies, led by China, India, and Brazil, represent major long-term adoption potential because of large cardiovascular disease burdens, expanding hospital networks, and rising access to specialty cardiovascular care, while Russia and South Africa remain influenced by regional procurement capacity and tertiary-care concentration.

ASEAN is gaining attention as Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines scale cardiac services at different speeds, with access shaped by public reimbursement, private hospital investment, and specialist availability. The GCC is distinguished by high healthcare investment, specialty hospital development, and demand for advanced cardiac technologies, although local workforce development, referral pathways, and long-term follow-up models remain essential for sustainable ICD care.

Key Country Insights for ICD Adoption

The United States is the most influential ICD market, supported by clinical guideline adoption, Medicare coverage, strong private payer participation, and a large base of electrophysiology centers. Canada maintains steady demand through provincial healthcare systems and organized cardiac referral pathways, while Mexico and Brazil are key Latin American countries where public-private access differences, tertiary hospital concentration, and affordability shape implant rates.

In Europe, Germany is a major ICD and cardiac resynchronization therapy defibrillator market because of strong hospital infrastructure, procedural capacity, and established reimbursement mechanisms. France, Italy, Spain, and the United Kingdom contribute stable demand through national health systems and guideline-based care, while Russia’s opportunity depends on regional cardiac center capacity, procurement conditions, and access to specialized electrophysiology services.

China and India are central to Asia-Pacific ICD adoption because of large patient populations, high cardiovascular disease burden, and expanding cardiovascular programs, but reimbursement depth, affordability, and specialist distribution remain decisive. Japan, South Korea, and Australia show more mature adoption patterns, supported by advanced hospitals, aging demographics, established regulatory frameworks, and wider use of remote cardiac monitoring in follow-up care.

Actionable Recommendations for ICD Industry Leaders

Industry leaders should prioritize evidence-based differentiation by demonstrating reductions in inappropriate shocks, infection risk, lead complications, alert burden, and total cost of care. Product roadmaps should emphasize remote monitoring interoperability, cybersecurity-by-design, battery longevity, MRI compatibility, device miniaturization, and patient-friendly follow-up workflows.

Commercial teams should align market access strategies with local reimbursement and health technology assessment requirements. In emerging markets, partnerships with tertiary hospitals, clinician training programs, financing models, referral network development, and post-implant monitoring infrastructure can expand access while protecting clinical outcomes.

Manufacturers should also invest in AI governance, real-world evidence generation, and registry collaboration. Transparent validation of algorithms, inclusive datasets, secure data handling, and clinician-controlled decision support will be critical for building trust among regulators, physicians, payers, and patients.

Research Methodology for ICD Market Insights

This executive summary is based on secondary research from authoritative clinical, regulatory, and public health sources, including cardiology society guidelines, public health statistics, medical device regulatory information, peer-reviewed literature, device safety communications, and hospital care pathway evidence. The analysis emphasizes verified factors affecting ICD demand, including cardiovascular disease burden, heart failure prevalence, reimbursement, technology adoption, electrophysiology infrastructure, and remote monitoring readiness.

Market interpretation was developed through triangulation across clinical practice trends, regional healthcare capacity, regulatory environments, adoption barriers, and digital health implementation factors. The methodology excludes unsupported market sizing claims and focuses on defensible insights relevant to implantable cardioverter defibrillator manufacturers, healthcare providers, payers, investors, procurement stakeholders, and digital health participants.

Conclusion: The Future of ICD Market Growth

The ICD market is entering a more connected, data-driven phase in which device performance, remote monitoring, AI-enabled triage, cybersecurity, and patient access will define competitive advantage. Clinical need remains durable because sudden cardiac death prevention is a high-priority component of modern cardiovascular care.

Organizations that combine strong clinical evidence, reliable device engineering, secure digital platforms, and localized access strategies will be best positioned to capture growth. As healthcare systems seek better outcomes and efficient follow-up, ICD innovation will increasingly be measured not only by implant activity but also by long-term patient safety, workflow efficiency, equitable access, and value-based care impact.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Implantable Cardioverter Defibrillators Market, by Device Type
7.1. Introduction
7.2. Subcutaneous ICDs
7.3. Transvenous ICDs
8. Implantable Cardioverter Defibrillators Market, by Product Type
8.1. Introduction
8.2. Pulse Generator
8.3. Electrodes
8.4. External Accessories
9. Implantable Cardioverter Defibrillators Market, by Therapy Type
9.1. Introduction
9.2. Defibrillation Therapy
9.3. Cardioversion Therapy
9.4. Anti-Tachycardia Pacing
9.5. Cardiac Resynchronization Therapy
10. Implantable Cardioverter Defibrillators Market, by Implantation Type
10.1. Introduction
10.2. Single Lead Implantation
10.3. Dual Lead Implantation
10.4. Triple Lead Implantation
11. Implantable Cardioverter Defibrillators Market, by Indication
11.1. Introduction
11.2. Primary Prevention
11.3. Secondary Prevention
12. Implantable Cardioverter Defibrillators Market, by Application
12.1. Introduction
12.2. Ventricular Tachycardia
12.3. Ventricular Fibrillation
12.4. Heart Failure
12.5. Sudden Cardiac Arrest (SCA) Prevention
13. Implantable Cardioverter Defibrillators Market, by Region
13.1. Asia-Pacific
13.2. North America
13.3. Latin America
13.4. Europe
13.5. Middle East
13.6. Africa
14. Implantable Cardioverter Defibrillators Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Implantable Cardioverter Defibrillators Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Abbott Laboratories
17.2. Angiplast Pvt Ltd.
17.3. Atrium Medical, Inc.
17.4. B. Braun Melsungen AG
17.5. Becton, Dickinson and Company
17.6. BIOTRONIK SE & Co. KG
17.7. Boston Scientific Corporation
17.8. Cardinal Health, Inc.
17.9. ConMed Corporation
17.10. ConvaTec Group PLC
17.11. Cook Medical Inc.
17.12. Fresenius Medical Care AG & Co. KGaA
17.13. Getinge AB
17.14. LivaNova PLC
17.15. Medtronic plc
17.16. Merit Medical Systems, Inc.
17.17. MicroPort Scientific Corporation
17.18. Olympus Corporation
17.19. Stryker Corporation
17.20. Teleflex Incorporated
17.21. ZOLL Medical Corporation
List of Figures
FIGURE 1. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY DEVICE TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY THERAPY TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY THERAPY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION TYPE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL SUBCUTANEOUS ICDS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL SUBCUTANEOUS ICDS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL SUBCUTANEOUS ICDS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL TRANSVENOUS ICDS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL TRANSVENOUS ICDS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL TRANSVENOUS ICDS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL PULSE GENERATOR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL PULSE GENERATOR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL PULSE GENERATOR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL ELECTRODES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL ELECTRODES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL ELECTRODES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL EXTERNAL ACCESSORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL EXTERNAL ACCESSORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL EXTERNAL ACCESSORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL DEFIBRILLATION THERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL DEFIBRILLATION THERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL DEFIBRILLATION THERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL CARDIOVERSION THERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL CARDIOVERSION THERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL CARDIOVERSION THERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL ANTI-TACHYCARDIA PACING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL ANTI-TACHYCARDIA PACING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL ANTI-TACHYCARDIA PACING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION TYPE, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL SINGLE LEAD IMPLANTATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL SINGLE LEAD IMPLANTATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL SINGLE LEAD IMPLANTATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL DUAL LEAD IMPLANTATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL DUAL LEAD IMPLANTATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL DUAL LEAD IMPLANTATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL TRIPLE LEAD IMPLANTATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL TRIPLE LEAD IMPLANTATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL TRIPLE LEAD IMPLANTATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL PRIMARY PREVENTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL PRIMARY PREVENTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL PRIMARY PREVENTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL SECONDARY PREVENTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL SECONDARY PREVENTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL SECONDARY PREVENTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL VENTRICULAR TACHYCARDIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL VENTRICULAR TACHYCARDIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL VENTRICULAR TACHYCARDIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL VENTRICULAR FIBRILLATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL VENTRICULAR FIBRILLATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL VENTRICULAR FIBRILLATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL HEART FAILURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL HEART FAILURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL HEART FAILURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL SUDDEN CARDIAC ARREST (SCA) PREVENTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL SUDDEN CARDIAC ARREST (SCA) PREVENTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL SUDDEN CARDIAC ARREST (SCA) PREVENTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 66. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 67. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 68. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION TYPE, 2017-2032 (USD MILLION)
TABLE 69. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 70. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 71. NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 73. NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 74. NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 75. NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION TYPE, 2017-2032 (USD MILLION)
TABLE 76. NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 77. NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 78. LATIN AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. LATIN AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 80. LATIN AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 81. LATIN AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 82. LATIN AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION TYPE, 2017-2032 (USD MILLION)
TABLE 83. LATIN AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 84. LATIN AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 85. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 87. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 88. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 89. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION TYPE, 2017-2032 (USD MILLION)
TABLE 90. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 91. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 92. MIDDLE EAST IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. MIDDLE EAST IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 94. MIDDLE EAST IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 95. MIDDLE EAST IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 96. MIDDLE EAST IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION TYPE, 2017-2032 (USD MILLION)
TABLE 97. MIDDLE EAST IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 98. MIDDLE EAST IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 99. AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 100. AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 101. AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 102. AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 103. AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION TYPE, 2017-2032 (USD MILLION)
TABLE 104. AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 105. AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 107. ASEAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 108. ASEAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 109. ASEAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 110. ASEAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 111. ASEAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION TYPE, 2017-2032 (USD MILLION)
TABLE 112. ASEAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 113. ASEAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 114. GCC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 115. GCC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 116. GCC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 117. GCC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 118. GCC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION TYPE, 2017-2032 (USD MILLION)
TABLE 119. GCC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 120. GCC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 121. EUROPEAN UNION IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 122. EUROPEAN UNION IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 123. EUROPEAN UNION IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 124. EUROPEAN UNION IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 125. EUROPEAN UNION IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION TYPE, 2017-2032 (USD MILLION)
TABLE 126. EUROPEAN UNION IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 127. EUROPEAN UNION IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 128. BRICS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 129. BRICS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 130. BRICS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 131. BRICS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 132. BRICS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION TYPE, 2017-2032 (USD MILLION)
TABLE 133. BRICS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 134. BRICS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 135. G7 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 136. G7 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 137. G7 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 138. G7 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 139. G7 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION TYPE, 2017-2032 (USD MILLION)
TABLE 140. G7 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 141. G7 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 142. NATO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 143. NATO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 144. NATO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 145. NATO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 146. NATO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION TYPE, 2017-2032 (USD MILLION)
TABLE 147. NATO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 148. NATO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 149. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 150. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 151. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 152. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 153. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 154. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION TYPE, 2017-2032 (USD MILLION)
TABLE 155. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 156. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 157. CANADA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 158. CANADA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 159. CANADA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 160. CANADA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 161. CANADA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION TYPE, 2017-2032 (USD MILLION)
TABLE 162. CANADA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 163. CANADA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 164. MEXICO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 165. MEXICO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 166. MEXICO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 167. MEXICO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 168. MEXICO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION TYPE, 2017-2032 (USD MILLION)
TABLE 169. MEXICO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 170. MEXICO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 171. BRAZIL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 172. BRAZIL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 173. BRAZIL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 174. BRAZIL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 175. BRAZIL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION TYPE, 2017-2032 (USD MILLION)
TABLE 176. BRAZIL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 177. BRAZIL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 178. UNITED KINGDOM IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 179. UNITED KINGDOM IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 180. UNITED KINGDOM IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 181. UNITED KINGDOM IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 182. UNITED KINGDOM IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION TYPE, 2017-2032 (USD MILLION)
TABLE 183. UNITED KINGDOM IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 184. UNITED KINGDOM IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 185. GERMANY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 186. GERMANY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 187. GERMANY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 188. GERMANY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 189. GERMANY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION TYPE, 2017-2032 (USD MILLION)
TABLE 190. GERMANY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 191. GERMANY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 192. FRANCE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 193. FRANCE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 194. FRANCE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 195. FRANCE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 196. FRANCE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION TYPE, 2017-2032 (USD MILLION)
TABLE 197. FRANCE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 198. FRANCE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 199. RUSSIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 200. RUSSIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 201. RUSSIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 202. RUSSIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 203. RUSSIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION TYPE, 2017-2032 (USD MILLION)
TABLE 204. RUSSIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 205. RUSSIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 206. ITALY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 207. ITALY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 208. ITALY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 209. ITALY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 210. ITALY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION TYPE, 2017-2032 (USD MILLION)
TABLE 211. ITALY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 212. ITALY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 213. SPAIN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 214. SPAIN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 215. SPAIN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 216. SPAIN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 217. SPAIN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION TYPE, 2017-2032 (USD MILLION)
TABLE 218. SPAIN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 219. SPAIN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 220. CHINA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 221. CHINA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 222. CHINA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 223. CHINA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 224. CHINA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION TYPE, 2017-2032 (USD MILLION)
TABLE 225. CHINA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 226. CHINA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 227. INDIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 228. INDIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 229. INDIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 230. INDIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 231. INDIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION TYPE, 2017-2032 (USD MILLION)
TABLE 232. INDIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 233. INDIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 234. JAPAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 235. JAPAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 236. JAPAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 237. JAPAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 238. JAPAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION TYPE, 2017-2032 (USD MILLION)
TABLE 239. JAPAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 240. JAPAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 241. AUSTRALIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 242. AUSTRALIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 243. AUSTRALIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 244. AUSTRALIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 245. AUSTRALIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION TYPE, 2017-2032 (USD MILLION)
TABLE 246. AUSTRALIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 247. AUSTRALIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 248. SOUTH KOREA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 249. SOUTH KOREA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 250. SOUTH KOREA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 251. SOUTH KOREA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 252. SOUTH KOREA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION TYPE, 2017-2032 (USD MILLION)
TABLE 253. SOUTH KOREA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 254. SOUTH KOREA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 255. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SHARE, BY KEY PLAYER, 2025
TABLE 256. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • Abbott Laboratories
  • Angiplast Pvt Ltd.
  • Atrium Medical, Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • ConMed Corporation
  • ConvaTec Group PLC
  • Cook Medical Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • Getinge AB
  • LivaNova PLC
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Olympus Corporation
  • Stryker Corporation
  • Teleflex Incorporated
  • ZOLL Medical Corporation

Table Information

Report AttributeDetails
No. of Pages188
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 5.28 Billion
Forecasted Market Value ( USD ) by 2032 $ 7.66 Billion
Compound Annual Growth Rate6.2%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Defibrillators Market - Global Forecast 2026-2032 - Product Image

Defibrillators Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
Implantable Cardioverter Defibrillators (ICD) - Global Strategic Business Report - Product Image

Implantable Cardioverter Defibrillators (ICD) - Global Strategic Business Report

  • Report
  • 416 Pages
  • Global
From
Implantable Cardioverter Defibrillators (ICDs) Market Report 2026 - Product Image

Implantable Cardioverter Defibrillators (ICDs) Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Defibrillator Market by Product (Implantable Cardioverter Defibrillator, External Defibrillator (Automated Defibrillator, Wearable Defibrillator, Manual Defibrillator)), End User (Hospitals & Clinics, Cardiac Centers, Homecare) - Global Forecast to 2030 - Product Image

Defibrillator Market by Product (Implantable Cardioverter Defibrillator, External Defibrillator (Automated Defibrillator, Wearable Defibrillator, Manual Defibrillator)), End User (Hospitals & Clinics, Cardiac Centers, Homecare) - Global Forecast to 2030

  • Report
  • 296 Pages
  • Global
From
Implantable Cardioverter Defibrillator Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030 - Product Image

Implantable Cardioverter Defibrillator Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030

  • Report
  • 184 Pages
  • Global
From

About the Market

The Implantable Cardioverter Defibrillator (ICD) market is a segment of the Cardiovascular Devices market. ICDs are medical devices used to treat life-threatening arrhythmias, or abnormal heart rhythms. They are implanted in the chest and monitor the heart's electrical activity. When an abnormal rhythm is detected, the device delivers an electrical shock to restore normal rhythm. ICDs are used to treat ventricular tachycardia and ventricular fibrillation, two of the most common causes of sudden cardiac death. The ICD market is driven by the increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive treatments. The market is expected to grow at a steady rate over the forecast period. Some of the major players in the ICD market include Medtronic, Abbott, Boston Scientific, Biotronik, LivaNova, and Sorin Group. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.